Kul Choeung

Introduction Probiotics have been studied as mucosal immune modulators targeting allergy outcomes. Several human probiotic trials tracking eczema and other forms of allergy have yielded inconsistent results [1,2,3,4,5,6]. Interestingly, two studies using the same probiotic, Lactobacillus rhamnosus GG, with similar study designs, resulted in different outcomes; either a decrease in eczema was obser ...